Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Asset Utilization Ratio (2018 - 2025)

VYNE Therapeutics (VYNE) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.01 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 45.9% year-over-year to 0.01, compared with a TTM value of 0.01 through Dec 2025, up 45.9%, and an annual FY2025 reading of 0.01, up 92.92% over the prior year.
  • Asset Utilization Ratio was 0.01 for Q4 2025 at VYNE Therapeutics, up from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.16 in Q1 2021 and bottomed at 0.0 in Q1 2024.
  • Average Asset Utilization Ratio over 5 years is 0.02, with a median of 0.01 recorded in 2023.
  • Peak annual rise in Asset Utilization Ratio hit 927.86% in 2021, while the deepest fall reached 93.98% in 2021.
  • Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then fell by 5.33% to 0.01 in 2022, then crashed by 38.98% to 0.01 in 2023, then fell by 3.05% to 0.01 in 2024, then surged by 45.9% to 0.01 in 2025.
  • Business Quant data shows Asset Utilization Ratio for VYNE at 0.01 in Q4 2025, 0.01 in Q2 2025, and 0.01 in Q1 2025.